"10.1371_journal.pone.0120648","plos one","2015-03-24T00:00:00Z","Jorge Carrillo; Luis Manuel Molinos-Albert; Maria Luisa Rodríguez de la Concepción; Silvia Marfil; Elisabet García; Ronald Derking; Rogier W Sanders; Bonaventura Clotet; Julià Blanco","Institut de Recerca de la SIDA-IrsiCaixa-HIVACAT, Badalona, Barcelona, Spain; Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America; Universitat Autònoma de Barcelona, Cerdanyola del Vallés, Barcelona, Spain; Universitat de Vic-Central de Catalunya, UVIC-UCC, Vic, Barcelona, Spain; Fundació Lluita contra la SIDA, Badalona, Barcelona, Spain","Conceived and designed the experiments: JC JB BC. Performed the experiments: JC LMM MLR SM EG. Analyzed the data: JC LMM MLR SM EG. Contributed reagents/materials/analysis tools: RWS RD. Wrote the paper: JC JB LMM.","BC and JB have received fees for consultancy from BMS, GILEAD, ViiV or Jansen outside the submitted work. The huCD4/mIgG protein is protected by the WO 2014/037490 patent. JC and JB are inventors of the patent WO2014/037490: “Methods for Identifying HIV-1 Neutralizing Antibodies”, in which the assay used for the identification of gp120/CD4 blocking antibodies is described. This does not alter the authors adherence to Plos One policies on sharing data and materials.","2015","03","Jorge Carrillo","JC",9,TRUE,3,5,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
